162 related articles for article (PubMed ID: 26137410)
1. Immune independent crosstalk between lymphoma and myeloid suppressor CD14
Zhang ZJ; Bulur PA; Dogan A; Gastineau DA; Dietz AB; Lin Y
Oncoimmunology; 2015 Apr; 4(4):e996470. PubMed ID: 26137410
[TBL] [Abstract][Full Text] [Related]
2. The CD14
Mengos AE; Gastineau DA; Gustafson MP
Front Immunol; 2019; 10():1147. PubMed ID: 31191529
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma.
Gustafson MP; Lin Y; Bleeker JS; Warad D; Tollefson MK; Crispen PL; Bulur PA; Harrington SM; Laborde RR; Gastineau DA; Leibovich BC; Cheville JC; Kwon ED; Dietz AB
Clin Cancer Res; 2015 Sep; 21(18):4224-33. PubMed ID: 25999436
[TBL] [Abstract][Full Text] [Related]
4. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.
Xiu B; Lin Y; Grote DM; Ziesmer SC; Gustafson MP; Maas ML; Zhang Z; Dietz AB; Porrata LF; Novak AJ; Liang AB; Yang ZZ; Ansell SM
Blood Cancer J; 2015 Jul; 5(7):e328. PubMed ID: 26230952
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive CD14
Javeed N; Gustafson MP; Dutta SK; Lin Y; Bamlet WR; Oberg AL; Petersen GM; Chari ST; Dietz AB; Mukhopadhyay D
Oncoimmunology; 2017; 6(1):e1252013. PubMed ID: 28197368
[TBL] [Abstract][Full Text] [Related]
6. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.
Gustafson MP; Lin Y; New KC; Bulur PA; O'Neill BP; Gastineau DA; Dietz AB
Neuro Oncol; 2010 Jul; 12(7):631-44. PubMed ID: 20179016
[TBL] [Abstract][Full Text] [Related]
7. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
Du J; Sun X; Song Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
[TBL] [Abstract][Full Text] [Related]
9. CD14(+) HLA-DR low/(-) monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma.
Khalifa KA; Badawy HM; Radwan WM; Shehata MA; Bassuoni MA
Int J Lab Hematol; 2014 Dec; 36(6):650-5. PubMed ID: 24636145
[TBL] [Abstract][Full Text] [Related]
10. Elevated frequencies of CD14
Xue G; Jiang M; Zhao R; Le A; Li J
Aging (Albany NY); 2021 Feb; 13(5):6236-6246. PubMed ID: 33640878
[TBL] [Abstract][Full Text] [Related]
11. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953
[No Abstract] [Full Text] [Related]
12. Expansion of CD10
Fraccarollo D; Neuser J; Möller J; Riehle C; Galuppo P; Bauersachs J
Elife; 2021 Jul; 10():. PubMed ID: 34289931
[TBL] [Abstract][Full Text] [Related]
13. Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses.
Laborde RR; Lin Y; Gustafson MP; Bulur PA; Dietz AB
Front Immunol; 2014; 5():147. PubMed ID: 24772111
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment.
Väyrynen JP; Haruki K; Väyrynen SA; Lau MC; Dias Costa A; Borowsky J; Zhao M; Ugai T; Kishikawa J; Akimoto N; Zhong R; Shi S; Chang TW; Fujiyoshi K; Arima K; Twombly TS; Da Silva A; Song M; Wu K; Zhang X; Chan AT; Nishihara R; Fuchs CS; Meyerhardt JA; Giannakis M; Ogino S; Nowak JA
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931472
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.
Lin Y; Gustafson MP; Bulur PA; Gastineau DA; Witzig TE; Dietz AB
Blood; 2011 Jan; 117(3):872-81. PubMed ID: 21063024
[TBL] [Abstract][Full Text] [Related]
16. Immunoparalysis: Clinical and immunological associations in SIRS and severe sepsis patients.
Papadopoulos P; Pistiki A; Theodorakopoulou M; Christodoulopoulou T; Damoraki G; Goukos D; Briassouli E; Dimopoulou I; Armaganidis A; Nanas S; Briassoulis G; Tsiodras S
Cytokine; 2017 Apr; 92():83-92. PubMed ID: 28119177
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive monocytes (CD14
Lima DS; Lemes RPG; Matos DM
Med Oncol; 2018 Feb; 35(3):36. PubMed ID: 29429058
[TBL] [Abstract][Full Text] [Related]
18. Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: profile comparison.
Brusa D; Simone M; Gontero P; Spadi R; Racca P; Micari J; Degiuli M; Carletto S; Tizzani A; Matera L
Int J Urol; 2013 Oct; 20(10):971-8. PubMed ID: 23421558
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive CD14
Viana CEM; Matos DM; Oliveira MF; da Costa AC; Filho TPA; Filho PAM; Nunes FMM; Nogueira Dos Santos T; Gonçalves RP; Queiroz JAN
Acta Trop; 2021 Dec; 224():106154. PubMed ID: 34599890
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer.
Tian T; Gu X; Zhang B; Liu Y; Yuan C; Shao L; Guo Y; Fan K
Cancer Biomark; 2015; 15(4):425-32. PubMed ID: 25792471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
